Concepedia

Publication | Open Access

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma

DOIFull Paper Access

30

Citations

16

References

2020

Year

Yuzhen Gao, Shipeng Chen, Somayeh Vafaei, Xiaoli Zhong
Frontiers in Oncology

Abstract

TICS might be used to predict PDAC patients with a better survival and greater chemotherapy benefit.

References

YearCitations

Page 1